CVS Health is expanding support for GLP-1 medications with a new $50 monthly copay for eligible Medicare patients through the CMS Medicare GLP-1 Bridge program starting July 1, 2026. They also introduced a $49 virtual MinuteClinic visit for weight management, allowing licensed clinicians to evaluate and prescribe GLP-1 therapy where appropriate. CVS pharmacists will provide personalized guidance and over-the-counter products to help manage common side effects, addressing key barriers to treatment adherence. This comprehensive approach aims to improve access, affordability, and ongoing patient support across CVS's 9,000 pharmacies and MinuteClinic locations.

More News (CVS)

Healthcare services market to reach $20.10T by 2035, driven by digital health and AI adoption.

The global healthcare services market, valued at $8.62 trillion in 2025, is projected to grow to $20.10 trillion by 2035 at a CAGR of 8.87%. Growth is driven by rising chronic diseases, aging populations, and increased demand for personalized and acc...

Market News

Bullish

4 days ago

CVS launches $50 monthly copay for Medicare GLP-1 meds and $49 virtual weight management visits

More News (CVS)

Healthcare services market to reach $20.10T by 2035, driven by digital health and AI adoption.

Invest & Trade with
#1 Award-Winning Investment Super App

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store

CVS launches $50 monthly copay for Medicare GLP-1 meds and $49 virtual weight management visits

More News (CVS)

Healthcare services market to reach $20.10T by 2035, driven by digital health and AI adoption.

Invest & Trade with#1 Award-Winning Investment Super App

iOS App Store

Google Play Store

Invest & Trade with
#1 Award-Winning Investment Super App